Recent Advances in Nanotechnology for the Management of Klebsiella pneumoniae-Related Infections

Biosensors (Basel). 2022 Dec 10;12(12):1155. doi: 10.3390/bios12121155.

Abstract

Klebsiella pneumoniae is an important human pathogen that causes diseases such as urinary tract infections, pneumonia, bloodstream infections, bacteremia, and sepsis. The rise of multidrug-resistant strains has severely limited the available treatments for K. pneumoniae infections. On the other hand, K. pneumoniae activity (and related infections) urgently requires improved management strategies. A growing number of medical applications are using nanotechnology, which uses materials with atomic or molecular dimensions, to diagnose, eliminate, or reduce the activity of different infections. In this review, we start with the traditional treatment and detection method for K. pneumoniae and then concentrate on selected studies (2015-2022) that investigated the application of nanoparticles separately and in combination with other techniques against K. pneumoniae.

Keywords: Klebsiella pneumoniae; antibacterial; detection; metallic nanoparticles; nanotechnology.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Humans
  • Klebsiella pneumoniae*
  • Nanotechnology
  • Urinary Tract Infections*

Substances

  • Anti-Bacterial Agents

Grants and funding

This article is the result of the research project approved by the student research committee of Kerman University of Medical Sciences under the number 400001085, which was carried out with the financial support of the Research and Technology Vice-Chancellor of this university.